Clinical Trials Logo

Hemorrhage, Intracranial clinical trials

View clinical trials related to Hemorrhage, Intracranial.

Filter by:
  • None
  • Page 1

NCT ID: NCT06027411 Recruiting - Stroke, Ischemic Clinical Trials

Assess the Clinical Effectiveness in AI Prioritising CT Heads

ACCEPT
Start date: March 27, 2024
Phase:
Study type: Observational [Patient Registry]

Non-Contrast Computed Tomography (NCCT) of the head is the most common imaging method used to assess patients attending the Emergency Department (ED) with a wide range of significant neurological presentations including trauma, stroke, seizure and reduced consciousness. Rapid review of the images supports clinical decision-making including treatment and onward referral. Radiologists, those reporting scans, often have significant backlogs and are unable to prioritise abnormal images of patients with time critical abnormalities. Similarly, identification of normal scans would support patient turnover in ED with significant waits and pressure on resources. To address this problem, Qure.AI has worked to develop the market approved qER algorithm, which is a software program that can analyse CT head to identify presence of abnormalities supporting workflow prioritisation. This study will trial the software in 4 NHS hospitals across the UK to evaluate the ability of the software to reduce the turnaround time of reporting scans with abnormalities that need to be prioritised.

NCT ID: NCT01845441 Terminated - Stroke Clinical Trials

Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions

Start date: April 2012
Phase: Phase 2
Study type: Interventional

Dexmedetomidine is a unique sedative medication able to provide sedation without causing respiratory depression and maintaining neurological functions. Patients having an acute ischemic stroke and need to undergo endovascular therapy require constant assessment of their neurological status prior, during and after the interventional procedure. In this study the investigators will compare the efficacy of Dexmedetomidine to other standard sedative medications in providing optimal sedative effect while maintaining neurological function.